Alpha-fetoprotein levels in maternal plasma and amniotic fluid during prostaglandin-induced mid-trimester abortions: the relation to fetal distress and death.
Alpha-fetoprotein (AFP) levels were measured in both plasma and amniotic fluid during 43 abortions induced with prostaglandin F2alpha (PGF2alpha) and their relationship to the induction-abortion interval and signs of fetal distress or intrauterine death examined. The mean plasma AFP levels showed a progressive rise after PGF2alpha administration but abnormally high levels were found infrequently until the time of delivery. Feto-maternal bleeding could explain the abnormally high plasma AFP levels which occurred early in a few cases. A shorter induction-abortion interval was found in patients with normal plasma AFP levels. Neither fetal distress nor intrauterine death were associated with abnormally high plasma AFP levels. No change in AFP levels in amniotic fluid was found.
D000028:Abortion, Induced; D000653:Amniotic Fluid / Q000378:metabolism*; D005260:Female; D005313:Fetal Death / Q000378:metabolism*; D005316:Fetal Distress / Q000378:metabolism*; D005326:Fetal Proteins / Q000378:metabolism*; D006801:Humans; D010121:Oxytocin / Q000627:therapeutic use; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000627:therapeutic use*; D013997:Time Factors; D000509:alpha-Fetoproteins / Q000378:metabolism*
D005326:Fetal Proteins; D011460:Prostaglandins F; D000509:alpha-Fetoproteins; D010121:Oxytocin